state of the art in long-term liver cancer survival(breakthrough in conception)(精) 内科 马曾辰
新华书店全新正版书籍 支持7天无理由
￥ 204.3 7.1折 ￥ 288 全新
库存3件
北京丰台
认证卖家担保交易快速发货售后保障
作者马曾辰
出版社科学出版社
ISBN9787030635440
出版时间2019-12
版次1
装帧其他
开本16
页数264页
字数390千字
定价288元
货号xhwx_1202005175
上书时间2024-06-26
- 在售商品 暂无
- 平均发货时间 29小时
- 好评率 暂无
商品详情
- 品相描述：全新
- 正版特价新书
- 商品描述
-
目录：
part ⅰ eighty-eight illustrative cases
case 1 recurrence 39 years after resection, total survival 43 years
case 2 a single resection, ongoing survival 48 years
case 3 two resections, total survival 44 years
case 4 a single resection, total survival 26 years
case 5 a single resection, total survival 34 years
case 6 a single resection of giant liver cancer, ongoing survival 44 years
case 7 a single resection, total survival 20 years
case 8 liver resection and resection of pulmonary metastasis, total survival 32 years
case 9 two resections, ongoing survival 40 years
case 10 liver resection and resection of pulmonary metastasis, total survival 25 years
case 11 a single resection, ongoing survival 40 years
case 12 oldest survivor, age 99, after liver resection and subsequent pulmonary metastasis resection, ongoing survival 40 years
case 13 a single resection, ongoing survival 40 years
case 14 a single resection, total survival 31 years
case 15 a single resection, total survival 34 years
case 16 a single resection, ongoing survival 36 years
case 17 a single resection, total survival 25 years
case 18 a single resection, ongoing survival 36 years
case 19 a single resection, total survival 29 years
case 20 a single resection, ongoing survival 35 years
case 21 a single resection, ongoing survival 35 years
case 22 two-step resection and resection of recurrence, ongoing survival 35 years
case 23 a single resection, ongoing survival 34 years
case 24 hepatic artery ligation and cannulation with infusion hemotherapy, ongoing survival 32 years
case 25 a single resection, total survival 30 years
case 26 a single resection, ongoing survival 31 years
case 27 two resections, ongoing survival 31 years
case 28 two resections and resection of pulmonary metastasis, total survival 20 years
case 29 a single resection, ongoing survival 31 years
case 30 a single resection, total survival 21 years
case 31 a single resection, total survival 26 years
case 32 two-step resection, total survival 26 years
case 33 a single resection, total survival 28 years
case 34 a single resection, ongoing survival 30 years
case 35 hepatic artery ligation and cannulation with lnfusion chemotherapy total survival 25 years
case 36 a single resection, ongoing survival 29 years
case 37 a single resection, total survival 20 years
case 38 two-step resection, ongoing survival 29 years
case 39 a single resection, ongoing survival 29 years
case 40 a single resection, ongoing survival 29 years
case 41 two resections, ongoing survival 29 years
case 42 two-step resection and resection of pulmonary metastasis, ongoing survival 28 years
case 43 two-step resection, ongoing survival 28 years
case 44 two resections, total survival 25 years
case 45 two resections, ongoing survival 28 years
case 46 two resections, total survival 27 years
case 47 liver resection and hepatic vein cancer thrombectomy, ongoing survival 28 years
case 48 liver resection and bile duct cancer thrombectomy, total survival 25 years
case 49 a single resection, ongoing survival 28 years
case 50 liver resection and portal vein cancer thrombectomy, ongoing survival 27 years
case 51 two-step resection, ongoing survival 27 years
case 52 a single resection, ongoing survival 27 years
case 53 a single resection, ongoing survival 27 years
case 54 a single resection, total survival 26 years
case 55 two-step resection, ongoing survival 26 years
case 56 a single liver resection, ongoing survival 24 years
case 57 two-step resection and resection of recurrence, ongoing survival 24 years
case 58 resection of bilateral lesions, ongoing survival 23 years
case 59 liver resection and hepatic vein cancer thrombectomy, ongoing survival 23 years
case 60 a single resection, ongoing survival 23 years
case 61 a single resection, ongoing survival 23 years
case 62 a single resection, ongoing survival 23years
case 63 a single resection, total survival 22 years
case 64 a single resection, ongoing survival 22 years
case 65 liver resection for metastases from colon cancer, ongoing survival 22 years
case 66 resection of hepatic hilum cancer, ongoing survival 22 years
case 67 a single resection, ongoing survival 22 years
case 68 a single resection, ongoing survival 22 years
case 69 a single resection in an 18 months , ongoing survival 22 years
case 70 a single resection, ongoing survival 22 years
case 71 a single resection, ongoing survival 22 years
case 72 liver resection for metastasis from colon cancer, total survival 21 years
case 73 a single resection, ongoing survival 21 years
case 74 a single resection, ongoing survival 21 years
case 75 three resections, ongoing survival 21 years
case 76 a single resection, ongoing survival 21 years
case 77 a single resection, ongoing survival 21 years
case 78 a single resection, ongoing survival 21 years
case 79 two resections, ongoing survival 21 years
case 80 a single resection, ongoing survival 20 years
case 81 two resections, ongoing survival 20 years
case 82 a single resection, ongoing survival 20 years
case 83 a single resection, ongoing survival 20 years
case 84 a single resection, ongoing survival 20 years
case 85 two resections, ongoing survival 20 years
case 86 a single resection, ongoing survival 20 years
case 87 a single resection, ongoing survival 20 years
case 88 two-step resection of liver lymphoma, ongoing survival 20 years
part ⅱ profile of 88 cases with long-term survival
part ⅲ gems totake home experiences and therapeutic approaches
3.1 hepatectomy is the most important treatment for liver cancer. long-term survival is sible alter a single liver resection
3.2 follow-up treatment with resection of recurrence can further improve therapeutic efficacy
3.3 long-term survival after 3 successive hepatectomies for liver cancer further strengthened the value of follow-up treatment
3.4 long-term survival after liver cancer resection and resection of pulmonary metastasis again highlighted the value of follow-up with definitive treatment
3.5 long-term survival by two-step liver resection after hepatic artery ligation with cannulation and lntra-arterial infusion chemotherapy to "modify" the cancer
3.6 liver resection with or followed by local treatment for liver cancer is a new approach to prolong survival
3.7 long-term survival after hepatectomy with transcatheter arterial chemoembolization for liver cancer
references
part ⅳ food for thought on the nature of liver cancer
4.1 liver cancer is a systemic disease as well as local disease
4.2 liver cancer is a "erocious tiger" as well as a "big docile cat
4.3 lung metastasis means the disease is in a late stage, is not entirely true
4.4 do not ignore the value of hepatic artery surgery in the treatment of liver cancer
4.5 multi-modality therapy is the developing trend, but surgical resection is absolutely irreceable in the prehensive treatment
references
part ⅴ irregular hepatectorny--the mainstay procedure in liver cancer resection
5.1 regular hepatectomy
5.2 irregular hepatectomy
5.3 application of lip-shaped hepatectomy in irregular hepatectomy
5.4 left regular and right irregular principle
5.5 irregular hepatectomy is particularly suitable for liver cancer at the hepatic hilum
5.6 itive evaluation of the hepatic hilum occlusion technique in hepatectomy
5.7 the concept of radical resection in liver cancer is different from other solid tumors
5.8 one must balance oute and operative risks
5.9 suggestions to reduce mortality
references
part ⅵ hepatic artery procedure and the two-step resection for liver cancer
6.1 mechanism of hepatic artery procedure in the treatment of primary liver cancer
6.2 hepatic artery ligation
6.3 hepatic artery cannulation
6.4 hepatic artery ligation with cannulation
6.5 operation in detail
6.6 the embedded pump-catheter infusion system
6.7 hepatic intra-arterial chemotherapy via the pump-catheter system
6.8 transcatheterarterial chemoembolization(tace)
6.9 two-step resection of liver cancer
6.10 typical cases in hepatic artery therapy
references
part ⅶ is elevated liver enzymes in liver cancer a surgical contraindication?
references
part ⅷ challenges and our preliminary efforts
references
acknowledgement
index
内容简介：
本书通过介绍复旦大学附属中山医院19995年收治的、88例肝癌术后20～48年长期生存的实例，分析这88例肝癌长期生存概况，结肝癌长期生存的八条经验及途径，从而提出我国外科学者对肝癌本质的认识，非规则肝切除是很主要的肝癌模式，肝动脉手术与肝癌二步切除是独具特的肝癌模式。本书以熟练的英文面向优选肝癌外科学者全面介绍了88例肝癌的经过、成功经验、技术要点和作者对肝癌外科内涵的理解。其写作力求深入浅出、图文并茂，可供肿瘤外科医师、青年医师以及医参阅读。
作者简介：
profeor zengchen ma(1940) enior oncologyurgeon and former chief of hepatic urgery atzhonghan hopital (fudan univerity) graduatedfrom faculty of medicinebeijing medicaluniverity in 1965.he received the mater degreein hepatic urgery from hanghai firt medicaluniverity in 1981.he wa alo viiting cholarin hepatic urgery at memorial loanketteringcancer center and mount inai medical centernew york city from 19901991. prof.ma ha engaged in clinical practice andreearch at the liver cancer intitutezhonghanhopital(fudan univerityformer hanghaimedical univerity)for 40 year.led by prof.zhaoyou tangmcaehe i the principal reearcherof everal major cientific project.hi maincontrib
— 没有更多了 —
以下为对购买帮助不大的评价